Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000935836-25-000708·Aprea Therapeutics, Inc.
Schedule 13G ownership disclosure
APREA THERAPEUTICS INC
Common Stock · CUSIP: 03836J201
Event date: 2025-11-13
- Filing-level shares
- 681,837.00
- Percent of class
- 9.9%
- LYTTON LAURENCE W
Shares: 681,837.00 · Class: 9.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000935836-25-000708
- Form type
- SCHEDULE 13G
- Filer
- Aprea Therapeutics, Inc.
- CIK
- CIK 1781983
- Filed
- Nov 17, 2025
- Reporting period
- Nov 13, 2025
- Description
- Schedule 13G beneficial ownership